| Style | Citing Format |
|---|---|
| MLA | Aghanour Ashtiani MM, et al.. "Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations." Medicinal Chemistry Research, vol. , no. , 2026, pp. -. |
| APA | Aghanour Ashtiani MM, Karimian S, Iraji A, Dastyafteh N, Mohammadikhanaposhtani M, Larijani B, Mahdavi M, Salehi P (2026). Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations. Medicinal Chemistry Research, (), -. |
| Chicago | Aghanour Ashtiani MM, Karimian S, Iraji A, Dastyafteh N, Mohammadikhanaposhtani M, Larijani B, Mahdavi M, Salehi P. "Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations." Medicinal Chemistry Research , no. (2026): -. |
| Harvard | Aghanour Ashtiani MM et al. (2026) 'Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations', Medicinal Chemistry Research, (), pp. -. |
| Vancouver | Aghanour Ashtiani MM, Karimian S, Iraji A, Dastyafteh N, Mohammadikhanaposhtani M, Larijani B, et al.. Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations. Medicinal Chemistry Research. 2026;():-. |
| BibTex | @article{ author = {Aghanour Ashtiani MM and Karimian S and Iraji A and Dastyafteh N and Mohammadikhanaposhtani M and Larijani B and Mahdavi M and Salehi P}, title = {Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations}, journal = {Medicinal Chemistry Research}, volume = {}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Aghanour Ashtiani MM AU - Karimian S AU - Iraji A AU - Dastyafteh N AU - Mohammadikhanaposhtani M AU - Larijani B AU - Mahdavi M AU - Salehi P TI - Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations JO - Medicinal Chemistry Research VL - IS - SP - EP - PY - 2026 ER - |